Abstract:Background Toll-like receptors (TLRs) are important components of the innate and adaptive immune systems, and abnormal TLR expression has been linked to a variety of cancers. However, there was a lack of clarity on the association of TLR stimulation with the carcinogenesis of cancer. The study's goal was to analyse the clinical importance of TLRs expression at the mRNA level in pan-cancer datasets, as well as the link between TLR expression and carcinogenesis, progression, and clinical prognosis.Methods The expression profile of TLRs derived from UCSC pan-cancer data was analysed in multiple dimensions, including clinical analysis, immunological subtype analysis, tumour microenvironment (TME) analysis, tumour stem cell correlation analysis, and drug sensitivity analysis. Additionally, we analyse protein-protein interactions, functional enrichment, and chromatin accessibility, as well as TLR expression in single-cell sequencing data.Results Our multi-omics analysis results imply that TLRs may operate as a biological marker for carcinogenesis and progression, a potential target for anti-tumour therapy, and a prognostic biomarker, laying the theoretical groundwork for future translational medicine research.Conclusion TLRs are involved in the formation of malignancies and can be explored in further detail as potential prognostic indicators. Key MessagesToll-like receptors (TLRs) are key factors in the process of the innate and adaptive immune response, and their aberrant expression of TLRs have been widely reported in various cancer. However, the association between TLRs stimulation and tumorigenesis of cancer has not been well clarified.In this study, in the pan-cancer data, integrated TLR family gene expression analysis, clinical correlation analysis, immune subtype correlation analysis, tumour microenvironment correlation analysis, tumour stem cell correlation analysis, and drug sensitivity correlation analysis were performed.TLRs play an important role in the development of tumours and can be studied in depth as potential prognostic markers.

Toll-like receptors AND dendritic cells

Toll-like Receptors and The Innate Immunity and Adaptive Immunity Mediated by Dendritic Cells

[Research progress on expression and function of Toll-like receptors in dendritic cells].

Toll-like Receptor 3 and Tumor Immunity

The Reciprocal Interactions between Natural Killer Cells and Dendritic Cells

Toll-like receptors in inflammation, infection and cancer

Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity

[Progress on the Role of Toll-like Receptors in Candida Albicans Infections].

Collaboration of Toll-like and RIG-I-like receptors in human dendritic cells: tRIGgering antiviral innate immune responses

Toll-like receptor control of the adaptive immune responses

Toll-like receptors: critical proteins linking innate and acquired immunity

The Role of Toll-Like Receptors (tlrs) in Pan-Cancer

Tissue-resident dendritic cells and diseases involving dendritic cell malfunction

[Innate immune recognition of the pathogenic parasites by toll-like receptors]

Toll-Like Receptors: Role in Dermatological Disease

Toll Like Receptors and Anti-Candida Albicans Immunity

Decoding Toll-like receptors: Recent insights and perspectives in innate immunity

Pattern recognition by Toll-like receptors

From Molecular Mechanisms to Clinical Applications

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

Toll-Like Receptors Mediate Opposing Dendritic Cell Effects on Treg/Th17 Balance in Mice With Intracerebral Hemorrhage